Related Experiment Video
Updated: May 25, 2026

Site-Specific Lysine Lactylation via Genetic Code Expansion in E. coli and Mammalian Cells
Published on: February 24, 2026
LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and
Klas Haraldson1, Vladimir I Kashuba, Alexey A Dmitriev
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Abstract:
Chromosome 3 specific NotI microarrays containing 180 NotI linking clones associated with 188 genes were hybridized to NotI representation probes prepared using matched tumor/normal samples from major epithelial cancers: breast (47 pairs), lung (40 pairs) cervical (43 pairs), kidney (34 pairs of clear cell renal cell carcinoma), colon (24 pairs), ovarian (25 pairs) and prostate (18 pairs). In all tested primary tumors (compared to normal controls) methylation and/or deletions was found. For the first time we showed that the gene LRRC3B was frequently methylated and/or deleted in breast carcinoma - 32% of samples, cervical - 35%, lung - 40%, renal - 35%, ovarian - 28%, colon - 33% and prostate cancer - 44%. To check these results bisulfite sequencing using cloned PCR products with representative two breast, one cervical, two renal, two ovarian and two colon cancer samples was performed. In all cases methylation was confirmed. Expression analysis using RT-qPCR showed that LRRC3B is strongly down-regulated at the latest stages of RCC and ovarian cancers. In addition we showed that LRRC3B exhibit strong cell growth inhibiting activity (more than 95%) in colony formation experiments in vitro in KRC/Y renal cell carcinoma line. All these data suggest that LRRC3B gene could be involved in the process of carcinogenesis as a tumor suppressor gene.
Insights
The LRRC3B gene is frequently methylated or deleted in multiple epithelial cancers, suggesting its role as a tumor suppressor. Down-regulation and growth inhibition were observed, supporting its involvement in carcinogenesis.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Alterations in chromosome 3 are common in epithelial cancers.
- The LRRC3B gene's role in carcinogenesis is largely unexplored.
Purpose of the Study:
- To investigate the frequency of methylation and deletion of LRRC3B in various epithelial cancers.
- To determine the functional impact of LRRC3B alterations on gene expression and cell growth.
Main Methods:
- NotI microarrays hybridized with tumor/normal samples from breast, lung, cervical, kidney, colon, ovarian, and prostate cancers.
- Bisulfite sequencing to confirm methylation.
- RT-qPCR for expression analysis.
- In vitro colony formation assays to assess growth inhibition.
Main Results:
- LRRC3B was frequently methylated and/or deleted across all tested epithelial cancers, with specific frequencies noted for each type.
- Methylation was confirmed by bisulfite sequencing.
- LRRC3B expression was down-regulated in late-stage renal cell carcinoma and ovarian cancers.
- LRRC3B demonstrated significant cell growth inhibitory activity in vitro.
Conclusions:
- LRRC3B alterations (methylation/deletion) are prevalent in epithelial cancers.
- LRRC3B down-regulation and its growth-inhibitory function suggest it acts as a tumor suppressor gene.
- LRRC3B may play a significant role in the process of carcinogenesis.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
lncRNA - Long Non-coding RNAs